IRS Awards Array Firms $16M to Develop Next-Generation Tests
November 16, 2010
IRS Awards Array Firms $16M to Develop Next-Generation Tests
Companies developing array- or biochip-based molecular diagnostics received a shot in the arm earlier this month under the Internal Revenue Service's $1 billion Qualifying Therapeutic Discovery Project program.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.